Brian Taylor Slingsby Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 21 hours ago
Brian Taylor Slingsby has an estimated net worth of at least $218.1 million*, as of Oct. 28, 2026. They own 7.8 million shares of MLYS stock. They have sold 1.7 million shares of MLYS stock since 2021, for an estimated $46.0 million.
Brian Taylor Slingsby $MLYS SEC Form 4 Insider Trading
Brian Taylor Slingsby has filed a total of 5 insider trades in $MLYS since 2021. Their most recent trade was a sale of 104,320 shares, made on Sep 22, 2026. Their largest trade was a sale of 1.0 million shares, made on Nov 20, 2025. We estimate that they now own 7.8 million shares of $MLYS, worth an estimated $172.0 million.
Insider Trading at $MLYS
There have been a total of 145 insider trades reported at $MLYS since 2021, with 8.2 million shares purchased and 3.7 million shares sold. The most active insider traders in $MLYS stock have been David Malcom Rodman, Jon Congleton, and Adam Scott Levy. The most recent trade was a sale of 75,000 shares reported by Jon Congleton (Chief Executive Officer), made on Sep 30, 2026.
History of Insider Stock Trades by Brian Taylor Slingsby
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MLYS
|
Sale | 104,320 | Sep 22, 2026 | Sept. 25, 2026, 6:02 a.m. |
|
MLYS
|
Sale | 1.0 million | Nov 20, 2025 | Nov. 21, 2025, 7:07 p.m. |
|
MLYS
|
Purchase | 259,259 | Mar 13, 2025 | April 25, 2025, 7:01 p.m. |
|
MLYS
|
Sale | 550,000 | Jul 24, 2024 | July 26, 2024, 9:45 p.m. |
|
MLYS
|
Purchase | 250,000 | Feb 14, 2023 | Feb. 16, 2023, 5:54 p.m. |
$MLYS Executives and Stock Owners with Insider Trades
-
David Malcom Rodman, Chief Medical Officer
-
Jon Congleton, Chief Executive Officer
-
Adam Scott Levy, CFO and Secretary
-
Eric Warren, Chief Commercial Officer
-
Adam Scott Levy, CFO, Chief Bus. Off. and Secy.
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.